A carregar...

Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient

SGLT2 inhibitors are only approved for use in adults with type 2 diabetes. However, because SGLT2 inhibitors have a mechanism of action that does not require the presence of endogenous insulin, these drugs should also be efficacious in type 1 diabetes where endogenous insulin production is greatly r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Endocrinol
Autor principal: Bell, David S. H.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4345240/
https://ncbi.nlm.nih.gov/pubmed/25785209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/676191
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!